Announcement
26 Sep 2024
In September 2024, US BARDA awarded USD 35 million to ModeX Therapeutics to develop two multispecific antibodies against COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
26 Sep 2024
Revocation date:
No revocation date
Updated: 26 Sep 2024
State aid, unspecified
In force
On 26 September 2024, the Biomedical Advanced Research and Development Authority (BARDA) awarded funding to ModeX Therapeutics to support the development of multispecific antibody for SARS-CoV-2. T...
Sign in to see more
Related State Acts
26 Sep 2023
United States of America: BARDA awards ModeX Therapeutics a contract to support the development of a monoclonal antibody against COVID-19
10 Apr 2023
United States of America: US Administration launches Project Next Gen initiative to fight against all COVID variants and future Coronaviruses
Threads
See all
This state act is not part of any Thread yet.